Skip to content

Now let me understand what GO:0046166 (glyceraldehyde-3-phosphate biosynthetic process) is by examining the model, and then I'll review the pathway structure.

Based on the GO-CAM model and protein information I've examined, I'll now provide a detailed review of GO-CAM model gomodel:6494e2e900002018.

Review of GO-CAM Model: gomodel:6494e2e900002018

Model Overview

  • Title: "Glyceraldehyde-3-phosphate biosynthetic process 1 (Mouse)"
  • Taxon: Mouse (NCBITaxon:10090)
  • Status: Production
  • Primary Process: Glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)

Model Structure and Flow Assessment

This model represents the glyceraldehyde-3-phosphate biosynthetic pathway in mouse. The pathway is well constructed with a clear flow of activities connected via the RO:0002413 ("provides input for") relationship, creating a logical progression through the metabolic pathway.

Pathway Flow Analysis:

The pathway begins with pyruvate carboxylase (Pcx) in the mitochondrial matrix and follows through several enzymatic steps, eventually culminating in glyceraldehyde-3-phosphate production:

  1. Pyruvate carboxylase (Pcx) → Malate dehydrogenase 2 (Mdh2) [mitochondria]
  2. Malate dehydrogenase 2 (Mdh2) → Malate transporter (Slc25a10) [mitochondrial inner membrane]
  3. Malate transporter (Slc25a10) → Malate dehydrogenase 1 (Mdh1) [cytosol]
  4. Malate dehydrogenase 1 (Mdh1) → Phosphoenolpyruvate carboxykinase (Pck1) [cytosol]
  5. Phosphoenolpyruvate carboxykinase (Pck1) → Enolase (Eno1) [cytosol]
  6. Enolase (Eno1) → Phosphoglycerate mutase (Pgam1) [cytosol]
  7. Phosphoglycerate mutase (Pgam1) → Phosphoglycerate kinase (Pgk1) [cytosol]
  8. Phosphoglycerate kinase (Pgk1) → Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) [cytosol]
  9. Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) → Triosephosphate isomerase (Tpi1) [cytosol]
  10. Triosephosphate isomerase (Tpi1) → Glycerol-3-phosphate dehydrogenase (Gpd1) [cytosol]

Evidence Assessment

The model has a good evidence base, with: - Most activities supported by experimental evidence codes (ECO:0000314, ECO:0000315) - References to primary literature (PMIDs) - Appropriate cellular locations specified for each activity

Strengths of the Model

  1. Complete pathway representation: The model represents the complete pathway from pyruvate to glyceraldehyde-3-phosphate.
  2. Proper cellular compartmentalization: Activities are appropriately localized to the correct cellular components (mitochondrial matrix, mitochondrial inner membrane, cytosol).
  3. Proper directionality: The causal connections between activities follow the correct biochemical flow using the "provides input for" relationship.
  4. Well-supported by evidence: Each activity has appropriate experimental evidence.
  5. Proper use of GO terms: Each protein is annotated with the appropriate molecular function GO term.

Areas for Improvement

  1. Evidence for causal relationships: While each activity has evidence, the causal associations (RO:0002413) do not have explicit evidence annotations. Adding evidence for these connections would strengthen the model.

  2. Possible missing branch points: The standard gluconeogenesis pathway typically involves branches and alternative routes. The model appears to represent a linear pathway, which may be a simplification.

  3. Terminal node clarification: The final activity (Gpd1) doesn't have any outgoing causal connections. It would be helpful to clarify if this is intended to be the endpoint of the pathway or if there are additional steps.

Consistency with GO-CAM Best Practices

The model follows GO-CAM best practices in several ways: - Appropriate use of molecular functions connected to gene products - Proper use of cellular component annotations - Clear causal relationships between activities - Biological process annotations for each activity

Biological Consistency

The model accurately represents the gluconeogenesis pathway leading to glyceraldehyde-3-phosphate production, with enzymes in their correct cellular locations and following the expected biochemical sequence.

Summary

This is a well-constructed GO-CAM model that accurately represents the glyceraldehyde-3-phosphate biosynthetic process in mouse. The model shows good pathway flow, proper use of GO terms, and is supported by experimental evidence. The main recommendation would be to add evidence for the causal relationships between activities and to clarify the terminal endpoint of the pathway.